Local treatment options for management of loco-regional esophageal squamous cell carcinoma
Journal Title: Revista de Medicină Militară - Year 2019, Vol 0, Issue 2
Abstract
Aim: Surgical treatment is the main treatment method for oesophagal cancer. The prognosis is poor due to high local recurrence and distant metastasis rates. The study aims to evaluate the most effective local treatment modality oesophagal squamous cell carcinoma (SCC) according to real-life data. Method: 136 patients were studied retrospectively. All patients were middle or lower oesophagal cancer and had the SCC histology. Patients were divided into the surgical resection, definitive CRT (dCRT), and multimodal treatment groups according to the curative local treatment they received. Result: 32.4% were in the surgical, 36% were in the dCRT, and 31.6% were in the multimodal group. Median disease-free survival was 21 months (95% CI 14-27) in the surgical group, 8 months (95% CI 4-11) in the dCRT group, and 18 months (95% CI 0-39) in the multimodal group (p=0.059). The median overall survival was found to be 40 months (95% CI 0-92) in the surgical group, 19 months (95% CI 15-22) in the dCRT group, and 54 months (95% CI 11-96) in the multimodal group (p=0.012). In the multimodal group, the number of patients receiving preoperative CRT was 25, and postoperative CRT was 18. Median OS was 47 months (95% CI 0-99) in the preoperative CRT group, and 64 months (NA) in the postoperative CRT group (p=0.302). Conclusion: DFS and OS contributions of multimodal treatment in oesophagal SCC have been shown in the present study. The addition of CRT to surgery in the preoperative or postoperative period has a contribution independently of the treatment sequence.
Authors and Affiliations
Tülay Eren, Gökşen İ. İmamoğlu, Fatih Yildiz, Süheyla A. Arslan, Sultan A. Kocacan, Salih Z. Çakar, Ozan Yazici, Doğan Yazılıtaş, Nuriye Özdemir, Berna Öksüzoğlu
Keywords
Related Articles
- EP ID EP610496
- DOI -
- Views 64
- Downloads 0
Clinical aspects of hearing loss associated with cisplatin therapy – a review
Introduction: Cisplatin is a well known platinum-based chemotherapeutic agent used for the treatment of diverse malignant tumours. A frequent side effect of cisplatin therapy is ototoxicity. Material and methods: Experim...
One health
-
The communication and promotion policies of the medical organizations in the marketing of Romanian healthcare services
The interdisciplinarity of the marketing department is due to the application of concepts, methods and marketing technics specific both to service and to social marketing. In addition to this fact, the attempt of the soc...
News and Perspectives on Treatment of Normal Pressure Internal Hydrocephalus
Many patients, usually over 60 years old, presenting presenile dementia associated with marked gait disorders, impaired balance, urinary incontinence, have been shown to have enlarged ventricles associated with relativel...
General considerations regarding the infections with the Escherichia coli pathogen
Escherichia coli is the species of the genus Escherichia with the greatest epidemiological impact. Escherichia coli infections are found mainly in places with poor hygiene; the infants with ages between 1 and 3 years old...